Thomas Doerner
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- interferon and immune responses
Papers in
-
- Systemic Lupus Erythematosus Research 4
- Urticaria and Related Conditions 3
-
- T-cell and B-cell Immunology 2
- Galectins and Cancer Biology 1
- Co-authors
- J. Shoham (4 shared papers)David Wallach (2 shared papers)Talia Hahn (1 shared paper)Hanoch Levavi (1 shared paper)Josef S Smolen (2 shared papers)Eitan Lunenfeld (2 shared papers)V. Cohen (1 shared paper)Marek Glezerman (2 shared papers)
- Journals
- RMD Open (2 papers)The Lancet (2 papers)Annals of the Rheumatic Diseases (2 papers)The Journal of Immunology (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- GermanyIsraelUnited States
In The Last Decade
Thomas Doerner
19 papers receiving 309 citations
Peers
Comparison fields: 5 of 63
- Rheumatology 88
- Immunology 90
- Epidemiology 134
- Dermatology 32
- Pathology and Forensic Medicine 42
Countries citing papers authored by Thomas Doerner
This map shows the geographic impact of Thomas Doerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Doerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Doerner more than expected).
Fields of papers citing papers by Thomas Doerner
This network shows the impact of papers produced by Thomas Doerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Doerner. The network helps show where Thomas Doerner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Doerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 136 | |
| 2 | 2020 | 46 | |
| 3 | 1988 | 36 | |
| 4 | 2021 | 21 | |
| 5 | 2003 | 21 | |
| 6 | 2004 | 13 | |
| 7 | 2009 | 12 | |
| 8 | 2021 | 12 | |
| 9 | 2016 | 10 | |
| 10 | Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis. | 1987 | 10 |
| 11 | Ianalumab (VAY736), a Dual Mode of Action Biologic Combining BAFF Receptor Inhibition with B Cell Depletion, for Treatment of Primary Sjogren's Syndrome: Results of an International Randomized, Placebo Controlled Dose Range Finding Study in 190 Patients | 2019 | 7 |
| 12 | 1987 | 5 | |
| 13 | 1972 | 4 | |
| 14 | 1987 | 3 | |
| 15 | Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C. | 1985 | 3 |
| 16 | 2015 | 2 | |
| 17 | 2001 | 1 | |
| 18 | 2012 | 1 | |
| 19 | [Beta-interferon for labial and genital herpes virus infection]. | 1989 | 1 |
| 20 | 1985 | 0 |
About Thomas Doerner
Thomas Doerner is a scholar working on Rheumatology, Immunology, Epidemiology, Physiology and Molecular Biology, having authored 20 papers that have together received 344 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (4 papers), Systemic Lupus Erythematosus Research (4 papers), Salivary Gland Disorders and Functions (4 papers), Urticaria and Related Conditions (3 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Galectins and Cancer Biology (1 paper) and Dermatologic Treatments and Research (1 paper). The work is most often cited by research in Rheumatology (88 citations), Immunology (90 citations), Epidemiology (134 citations), Dermatology (32 citations) and Pathology and Forensic Medicine (42 citations). Thomas Doerner has collaborated with scholars based in Germany, Israel and United States. Frequent co-authors include J. Shoham, David Wallach, Talia Hahn, Hanoch Levavi, Josef S Smolen, Eitan Lunenfeld, V. Cohen, Marek Glezerman, I Sarov and M Revel. Their work appears in journals such as RMD Open, The Lancet, Annals of the Rheumatic Diseases, The Journal of Immunology and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.